Iridex (IRIX) Income from Continuing Operations (2010 - 2026)
Iridex (IRIX) recorded quarterly Income from Continuing Operations of 524000.0 in Q2 2026, up 38.64% quarter-over-quarter from 854000.0 in Q1 2026, and up 68.92% on a YoY basis from 310205.06 in Q2 2025.
Iridex (IRIX) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Iridex's Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 524000.0 for Q2 2026.
- In Q2 2026, Income from Continuing Operations rose 68.92% year-over-year to 524000.0; the TTM figure through Apr 2026 stood at 3945000.0 (down 354.52% YoY), while the FY2026 annual figure was 5107000.0, down 2139.91% from the prior year.
- Income from Continuing Operations was 524000.0 for Q2 2026 at Iridex, up from 854000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 7848000.0 in Q4 2024 to a low of 3464000.0 in Q1 2024.
- Historically, Income from Continuing Operations has averaged 691055.56 across 5 years, with a median of 1720000.0 in 2023.
- The sharpest annual moves came in 2022 and 2023: Income from Continuing Operations slumped 260.88% in 2022, then surged 654.88% in 2023.
- A 5-year view of Income from Continuing Operations shows it stood at 1210000.0 in 2022, then soared by 654.88% to 6714000.0 in 2023, then advanced by 16.89% to 7848000.0 in 2024, then sank by 120.04% to 1573000.0 in 2025, then jumped by 66.69% to 524000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 524000.0 (Q2 2026), 854000.0 (Q1 2026), and 1573000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Iridex | 19.91 Mn | 15.31 Mn | 4.74 Mn | -524,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -524,000.00 |
| Jan 3, 2026 | -854,000.00 |
| Sep 27, 2025 | -1.57 Mn |
| Jun 28, 2025 | -994,000.00 |
| Mar 29, 2025 | -1.69 Mn |
| Dec 28, 2024 | 7.85 Mn |
| Sep 28, 2024 | -1.93 Mn |
| Jun 29, 2024 | -2.68 Mn |
| Mar 30, 2024 | -3.46 Mn |
| Dec 30, 2023 | 6.71 Mn |
| Sep 30, 2023 | -1.75 Mn |
| Jul 1, 2023 | -2.77 Mn |
| Apr 1, 2023 | -2.09 Mn |
| Dec 31, 2022 | -1.21 Mn |
| Oct 1, 2022 | -1.77 Mn |
| Jul 2, 2022 | -2.24 Mn |
| Apr 2, 2022 | -2.39 Mn |
| Jan 1, 2022 | 925,000.00 |
| Oct 2, 2021 | -2.17 Mn |
| Jul 3, 2021 | 1.39 Mn |